Variant report
Variant | esv3360086 |
---|---|
Chromosome Location | chr5:35841687-35842066 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs190887077 | chr5:35841701-35841702 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs182842299 | chr5:35841708-35841709 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs532288827 | chr5:35841733-35841734 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs552459111 | chr5:35841802-35841803 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs535117962 | chr5:35841809-35841810 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs202103901 | chr5:35841810-35841811 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs62355266 | chr5:35841816-35841817 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs534820035 | chr5:35841819-35841820 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs548126506 | chr5:35841821-35841822 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs12054901 | chr5:35841832-35841833 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs370914818 | chr5:35841840-35841841 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs188141608 | chr5:35841846-35841847 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs74192116 | chr5:35841847-35841848 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs62355267 | chr5:35841862-35841863 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs536014114 | chr5:35841865-35841866 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs556981340 | chr5:35841866-35841867 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs575875832 | chr5:35841869-35841870 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs62355268 | chr5:35841872-35841873 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs183878302 | chr5:35841890-35841891 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs563731905 | chr5:35841897-35841898 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs74193102 | chr5:35841918-35841919 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs572553753 | chr5:35841925-35841926 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs536137997 | chr5:35841948-35841949 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs200303557 | chr5:35841956-35841957 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs556079072 | chr5:35841962-35841963 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs538937000 | chr5:35841963-35841964 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs116520598 | chr5:35841978-35841979 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs572509576 | chr5:35841982-35841983 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs200968643 | chr5:35842035-35842036 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Myofibroblastic sarcoma | 19369631 | CNVD |
Cervical squamous cell carcinoma | 21590768 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Liposarcoma | 21253554 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Cervical cancer | 21062161 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Oral cancer | 21386901 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Cervical cancer | 18559093 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Gastric cancer | 22152101 | CNVD |
Oesophago-gastric ulcer | 22152101 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Multiple myeloma | 17550852 | CNVD |
prenatal diagnosis | 22389664 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Bladder cancer | 21909424 | CNVD |
DNA damage stimulus | 22844521 | CNVD |
DNA repair | 22844521 | CNVD |
Breast cancer | 21785460 | CNVD |
Spinal muscular atrophy | 22422766 | CNVD |
Spinal muscular atrophy | 22558076 | CNVD |
Spinal muscular atrophy | 21320981 | CNVD |
Spinal muscular atrophy | 21762474 | CNVD |
Breast cancer | 21858162 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Cancer | 16751803 | CNVD |
Breast cancer | 16608533 | CNVD |
Autism | 22495311 | CNVD |
Melanoma | 18172304 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Intellectual disability | 22102821 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21183584 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Breast cancer | 17603634 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Lung cancer | 18438408 | CNVD |
Glioma | 20126413 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Breast cancer | 22032731 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Prostate cancer | 18632612 | CNVD |
Medulloblastoma | 19270706 | CNVD |
Breast cancer | 19553991 | CNVD |
Lung cancer | 19553991 | CNVD |
Melanoma | 19553991 | CNVD |
Ovarian cancer | 19553991 | CNVD |
Prostate cancer | 19553991 | CNVD |
Non-small cell lung cancer | 17156491 | CNVD |
Breast cancer | 17133270 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18694510 | CNVD |
Breast cancer | 17393978 | CNVD |
Pleomorphic liposarcoma | 18784837 | CNVD |
Acute lymphoblastic leukemia | 17640729 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Lung cancer | 19153074 | CNVD |
Breast cancer | 21364760 | CNVD |
Cornelia de Lange syndrome | 21085971 | CNVD |
Autism | 21701786 | CNVD |
Cervical cancer | 16585170 | CNVD |
Ovarian clear cell carcinoma | 19293255 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 22522925 | CNVD |
Prostate cancer | 21147910 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:35839000-35841800 | Enhancers | Primary T helper memory cells from peripheral blood 2 | blood |
2 | chr5:35839000-35842000 | Enhancers | Primary T helper 17 cells PMA-I stimulated | -- |
3 | chr5:35840800-35841800 | Enhancers | Primary T helper cells PMA-I stimulated | -- |
4 | chr5:35841600-35842600 | Weak transcription | Primary T helper naive cells fromperipheralblood | blood |
5 | chr5:35841600-35842600 | Weak transcription | Primary T helper memory cells from peripheral blood 1 | blood |
6 | chr5:35841600-35845200 | Weak transcription | Primary T killer memory cells from peripheral blood | blood |
7 | chr5:35841800-35842800 | Weak transcription | Primary T helper cells PMA-I stimulated | -- |
8 | chr5:35842000-35842400 | Weak transcription | Primary T helper 17 cells PMA-I stimulated | -- |